Citation Impact

Citing Papers

Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation
2008 StandoutNobel
Crystal Structure of the Second LNS/LG Domain from Neurexin 1α
2006 StandoutNobel
Structural Basis of Transcription
2004 StandoutNobel
Circadian variations of infarct size in acute myocardial infarction
2011
Generation of Monomeric Reversibly Switchable Red Fluorescent Proteins for Far-Field Fluorescence Nanoscopy
2008 StandoutNobel
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
QM/MM Methods for Biomolecular Systems
2009 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Lysosomes: fusion and function
2007 Standout
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
2002 Standout
Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window
2010
Mortality risk among hemodialysis patients receiving different vitamin D analogs
2006
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Smad transcription factors
2005 Standout
Redox distress and genetic defects conspire in systemic autoinflammatory diseases
2015
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Vitamin D and vascular calcification
2007
Smads and early developmental signaling by the TGFβ superfamily
1998
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System
2003
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
2010
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
2002
Potentiation of C-type natriuretic peptide with ultrasound and microbubbles to prevent neointimal formation after vascular injury in rats
2003
Very fast empirical prediction and rationalization of protein pKa values
2005 Standout
Store-Operated Calcium Channels
2005 Standout
Dictyostelium CBP3 associates with actin cytoskeleton and is related to slug migration
2005
Cilostazol (Pletal®): A Dual Inhibitor of Cyclic Nucleotide Phosphodiesterase Type 3 and Adenosine Uptake
2001
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Photolyase/cryptochrome blue-light photoreceptors use photon energy to repair DNA and reset the circadian clock
2002 StandoutNobel
Circadian control of the immune system
2013 Standout
Exercise builds brain health: key roles of growth factor cascades and inflammation
2007 Standout
Nuclear exclusion of Smad2 is a mechanism leading to loss of competence
2002 StandoutNobel
Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States
2007
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
2003 StandoutNature
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues
2002
Recent advances in technology for measuring and manipulating cell signals
2000 StandoutNobel
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
2008
The small RNA repertoire of Dictyostelium discoideum and its regulation by components of the RNAi pathway
2007 StandoutNobel
Evidence for a vesicle-mediated maintenance of store-operated calcium channels in a human embryonic kidney cell line
2000
Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38
2008
Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells
2005
Endosome maturation
2011 Standout
How cells read TGF-β signals
2000 Standout
The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis
2004
Exercise affects energy metabolism and neural plasticity‐related proteins in the hippocampus as revealed by proteomic analysis
2006
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Characterization of a Catalytic Ligand Bridging Metal Ions in Phosphodiesterases 4 and 5 by Molecular Dynamics Simulations and Hybrid Quantum Mechanical/Molecular Mechanical Calculations
2006
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
2010 Standout
Cell Movement Is Guided by the Rigidity of the Substrate
2000 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Endoplasmic reticulum of animal cells and its organization into structural and functional domains
2001
Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice
2015
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
The Genome of Melanoplus sanguinipes Entomopoxvirus
1999
Cryptochrome: The Second Photoactive Pigment in the Eye and Its Role in Circadian Photoreception
2000 StandoutNobel
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
2002
Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway
1999
Vitamin D and Health: Perspectives From Mice and Man
2008
A Combined Experimental and Theoretical Study of Divalent Metal Ion Selectivity and Function in Proteins:  Application to E. coli Ribonuclease H1
2003
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Dynamic redistribution of calmodulin in HeLa cells during cell division as revealed by a GFP-calmodulin fusion protein technique
1999 StandoutNobel
Quantifying Free Energy Profiles of Proton Transfer Reactions in Solution and Proteins by Using a Diabatic FDFT Mapping
2008 StandoutNobel
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
The Role of Intraorganellar Ca2+In Late Endosome–Lysosome Heterotypic Fusion and in the Reformation of Lysosomes from Hybrid Organelles
2000
Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography
2008
Role of Phosphodiesterase 3 in NO/cGMP-Mediated Antiinflammatory Effects in Vascular Smooth Muscle Cells
2003
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Novel Platelet Inhibitors
2001
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
2002
Annexins: From Structure to Function
2002 Standout
Microglial M1/M2 polarization and metabolic states
2015 Standout
Principles Governing Mg, Ca, and Zn Binding and Selectivity in Proteins
2003
Insulin Resistance and Environmental Pollutants: Experimental Evidence and Future Perspectives
2013
Cytosolic Free Calcium and the Cytoskeleton in the Control of Leukocyte Chemotaxis
1998
Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling
2007 Standout
Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues
2002
The Concise Guide toPHARMACOLOGY2013/14: Enzymes
2013
Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice
2017 StandoutNobel
Structure and Function of DNA Photolyase and Cryptochrome Blue-Light Photoreceptors
2003 StandoutNobel
1,25(OH) 2 vitamin D 3 ‐dependent inhibition of platelet Ca 2+ signaling and thrombus formation in klotho‐deficient mice
2014

Works of Toshiki Sudo being referenced

Annexin XI may be involved in Ca2+‐ or GTP‐γS‐induced insulin secretion in the pancreatic β‐cell
2000
CLOCK regulates circadian platelet activity
2008
Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats
2000
Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury model
2000
Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets
2003
Regulation of Calcyclin (S100A6) Binding by Alternative Splicing in the N-terminal Regulatory Domain of Annexin XI Isoforms
1998
Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity
2000
Ca2+ Signaling and Intracellular Ca2+ Binding Proteins
1996
Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2
2009
Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice
2004
Characterization of the calcyclin (S100A6) binding site of annexin XI‐A by site‐directed mutagenesis
1999
Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility
2000
Rankless by CCL
2026